{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:42:56Z","timestamp":1777966976481,"version":"3.51.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Malignant primary cardiac tumors require multimodal approaches including surgery, chemotherapy and radiotherapy, but these treatments can be associated with cardiovascular complications. However, few reports have described the cardiovascular complications related to primary cardiac tumor treatment because of their rarity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Clinical records of patients with primary cardiac tumors treated at Kyushu University Hospital from January 2010 to August 2021 were retrospectively examined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 47 primary cardiac tumor patients, 13 (28%) were diagnosed with malignancy, including 5 angiosarcomas, 3 intimal sarcomas, 3 diffuse large B-cell lymphomas, 1 Ewing\u2019s sarcoma and 1 fibrosarcoma. Cardiovascular events were observed in 10 patients (77%), including cardiac dysfunction in 6 patients, arrhythmias in 5 patients, right heart failure in 2 patients, and excessively prolonged prothrombin time due to the combination of warfarin and chemotherapy in 1 patient. Two patients who showed notable cardiac complications are described. Case A involved a 69-year-old woman who underwent surgery for a left atrial intimal sarcoma, followed by postoperative chemotherapy with doxorubicin plus ifosfamide and radiotherapy. After three cycles of chemotherapy and sequential radiotherapy, her left ventricular ejection fraction decreased to 34%, and ongoing heart failure therapy was required. Case B involved a 66-year-old man who received chemotherapy for primary cardiac lymphoma, resulting in tumor shrinkage. However, due to tumor involvement of the intraventricular septum, atrioventricular block developed, requiring cardiac pacemaker implantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High incidences of cardiac failure and arrhythmias were observed during multimodal treatments for malignant primary cardiac tumors. Proper management of complications may lead to a favorable prognosis in patients with malignant primary cardiac tumors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyae138","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:37:02Z","timestamp":1728560222000},"page":"113-122","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3024-1018","authenticated-orcid":false,"given":"Kanami","family":"Furukawa","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, Japan Community Healthcare Organization Kyushu Hospital , Kitakyushu, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Oncology and Social Medicine, Kyushu University Graduate School of Medical Sciences , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Department of Hematology , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]},{"name":"Kyushu University Hospital , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Hematology , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]},{"name":"Kyushu University Hospital , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9014-6382","authenticated-orcid":false,"given":"Kenji","family":"Tsuchihashi","sequence":"additional","affiliation":[{"name":"Department of Hematology , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]},{"name":"Kyushu University Hospital , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Isobe","sequence":"additional","affiliation":[{"name":"Department of Oncology and Social Medicine, Kyushu University Graduate School of Medical Sciences , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ariyama","sequence":"additional","affiliation":[{"name":"Department of Oncology, Kitakyushu Municipal Medical Center , Kitakyushu, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Fukata","sequence":"additional","affiliation":[{"name":"Department of Hematology , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]},{"name":"Kyushu University Hospital , Oncology and Cardiovascular Medicine, , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kusaba","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hamanomachi Hospital , Chuo-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shiose","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Kyushu University Hospital , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eishi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Oncology and Social Medicine, Kyushu University Graduate School of Medical Sciences , Higashi-ku, Fukuoka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"2025020413015502300_ref1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0002-9149(68)90289-0","article-title":"The heart in malignant melanoma. A study of 70 autopsy cases","volume":"21","author":"Glancy","year":"1968","journal-title":"Am J Cardiol"},{"key":"2025020413015502300_ref2","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/S0003-4975(99)00700-6","article-title":"Primary cardiac tumors: early and late results of surgical treatment in 91 patients","volume":"68","author":"Centofanti","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"2025020413015502300_ref3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00000658-198002000-00001","article-title":"Primary cardiac tumors","volume":"191","author":"Silverman","year":"1980","journal-title":"Ann Surg"},{"key":"2025020413015502300_ref4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11748-013-0214-8","article-title":"Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences","volume":"61","author":"Amano","year":"2013","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2025020413015502300_ref5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1080\/0284186X.2021.1950923","article-title":"Primary cardiac lymphoma: the management and outcome of a single-centre cohort of 22 patients","volume":"60","author":"Wei","year":"2021","journal-title":"Acta Oncol"},{"key":"2025020413015502300_ref6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejca.2013.09.012","article-title":"Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group","volume":"50","author":"Isambert","year":"2014","journal-title":"Eur J Cancer"},{"key":"2025020413015502300_ref7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/cam4.1897","article-title":"Primary cardiac sarcomas: a multi-national retrospective review","volume":"8","author":"Chen","year":"2019","journal-title":"Cancer Med"},{"key":"2025020413015502300_ref8","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2025020413015502300_ref9","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"Nimwegen","year":"2017","journal-title":"Blood"},{"key":"2025020413015502300_ref10","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2025020413015502300_ref11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/medicina58020280","article-title":"St. Thomas modified cardioplegia effects on myoblasts\u2019 viability and morphology","volume":"58","author":"Nowicki","year":"2022","journal-title":"Medicina"},{"key":"2025020413015502300_ref12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41420-018-0031-z","article-title":"Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery","volume":"4","author":"Nardi","year":"2018","journal-title":"Cell Death Discov"},{"key":"2025020413015502300_ref13","first-page":"169","article-title":"Change of oxidative stress in cases of cardiac and aortic surgeries","volume":"38","author":"Inagaki","year":"2009","journal-title":"Cardiovasc Surg"},{"key":"2025020413015502300_ref14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbcan.2013.12.002","article-title":"DNA torsion, and chromatin dynamics","volume":"1845","author":"Yang","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2025020413015502300_ref15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"key":"2025020413015502300_ref16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2014.56.1373","article-title":"Individual prediction of heart failure among childhood cancer survivors","volume":"33","author":"Chow","year":"2015","journal-title":"J Clin Oncol"},{"key":"2025020413015502300_ref17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pcad.2010.06.007","article-title":"Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?","volume":"53","author":"Sawyer","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"2025020413015502300_ref18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025020413015502300_ref19","first-page":"108","article-title":"Surgical management of breast cancer with cardiotoxicity induced by neoadjuvant chemotherapy of anthracycline","volume":"35","author":"Ayabe","year":"2011","journal-title":"J Miyazaki M A"},{"key":"2025020413015502300_ref20","volume-title":"Radiation Therapy Induced Cardiac Toxicity","author":"Hufnagle","year":"2022"},{"key":"2025020413015502300_ref21","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.jacc.2017.09.1095","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025020413015502300_ref22","doi-asserted-by":"publisher","first-page":"3579143","DOI":"10.1155\/2020\/3579143","article-title":"Oxidative stress in radiation-induced cardiotoxicity","volume":"2020","author":"Ping","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"2025020413015502300_ref23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10554-020-01976-5","article-title":"Association between clinical risk factors and left ventricular function in patients with breast cancer following chemotherapy","volume":"37","author":"Yamashita","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025020413015502300_ref24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025020413015502300_ref25","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.jacc.2011.08.005","article-title":"Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia","volume":"58","author":"Miyake","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025020413015502300_ref26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12185-020-02881-2","article-title":"A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019","volume":"112","author":"Chen","year":"2020","journal-title":"Int J Hematol"},{"key":"2025020413015502300_ref27","first-page":"500","article-title":"Open heart surgery and arrhythmia (in Japanese)","volume":"1","author":"Tanaka","year":"1969","journal-title":"Heart"},{"key":"2025020413015502300_ref28","first-page":"1332","article-title":"Proarrhythmic complications related to cancer treatment (in Japanese)","volume":"52","author":"Shoji","year":"2020","journal-title":"Heart"},{"key":"2025020413015502300_ref29","doi-asserted-by":"publisher","first-page":"4938287","DOI":"10.1155\/2023\/4938287","article-title":"Oxidative stress and pyroptosis in doxorubicin-induced heart failure and atrial fibrillation","volume":"2023","author":"Ping","year":"2023","journal-title":"Oxid Med Cell Longev"},{"key":"2025020413015502300_ref30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fonc.2015.00039","article-title":"Radiation-induced heart disease: pathologic abnormalities and putative mechanisms","volume":"5","author":"Taunk","year":"2015","journal-title":"Front Oncol"},{"key":"2025020413015502300_ref31","doi-asserted-by":"publisher","first-page":"621289","DOI":"10.3389\/fonc.2021.621289","article-title":"Case report: adjuvant radiotherapy can be an effective treatment for intimal sarcoma of the heart","volume":"11","author":"Romanowska","year":"2021","journal-title":"Front Oncol"},{"key":"2025020413015502300_ref32","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association","volume":"137","author":"Mehta","year":"2018","journal-title":"Circulation"},{"key":"2025020413015502300_ref33","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/2\/113\/59695289\/hyae138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/2\/113\/59695289\/hyae138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T13:02:32Z","timestamp":1738674152000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/55\/2\/113\/7816288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,10,10]]},"published-print":{"date-parts":[[2025,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyae138","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,10,10]]}}}